DOJ

Dept. of Justice subpoenas Aegerion

Dept. of Justice subpoenas Aegerion

By

The drugmaker announced Friday that the DOJ wants documents regarding sales and marketing of Juxtapid, its drug for an ultra-rare lipid disorder.

Business briefs: GSK, DOJ, Sanofi, Flashpoint Medica

GSK boots Shanghai R&D head over data fabrication; DOJ backs off of Plan B; Sanofi scores approval for new flu vaccine; laurels for Flashpoint Medica's Charlene Prounis

Email Newsletters